A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment

~56 mi. (Ashkelon, Israel, +142 more cities)

Barzilai Medical Center

del(11)(q10), +27 more biomarkers

Myelofibrosis

imetelstat, +1 more drug

targeted therapy

A Study of LOXO-292 in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer

~63 mi. (Jerusalem, Israel, +78 more cities)

Shaare Zedek Medical Center

RET Fusion, +1 more biomarker

Adrenal Gland Pheochromocytoma, +5 more conditions

selpercatinib

targeted therapy

A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)

~88 mi. (Ramat Gan, Israel, +356 more cities)

Sheba Medical Center

HER2 Positive

Invasive Breast Carcinoma

fam-trastuzumab deruxtecan

targeted therapy

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

~88 mi. (Tel Aviv, Israel, +201 more cities)

Tel Aviv Sourasky Medical Center /ID# 221896

Myelodysplastic Syndromes

azacitidine, +1 more drug

chemotherapy

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)

~88 mi. (Ramat Gan, Israel, +127 more cities)

The Chaim Sheba Medical Center /ID# 214305

Acute Myeloid Leukemia

azacitidine, +2 more drugs

chemotherapy

A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy

~88 mi. (Tel Aviv, Israel, +197 more cities)

Tel Aviv Sourasky Medical Center /ID# 239698

BCR-ABL1 Fusion, +47 more biomarkers

Acute Myeloid Leukemia

azacitidine, +1 more drug

chemotherapy

Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

~88 mi. (Tel Aviv, Israel, +189 more cities)

Tel Aviv Sourasky Medical Center /ID# 219135

del(11)(q10), +27 more biomarkers

Myelofibrosis Transformation in Essential Thrombocythemia, +2 more conditions

navitoclax, +1 more drug

targeted therapy

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

~88 mi. (Petaẖ Tiqwa, Israel, +177 more cities)

Schneider Children's Medical Center of Israel

BCR-ABL1 Fusion, +1 more biomarker

Acute Lymphoblastic Leukemia

allogeneic hematopoietic stem cell transplantation, +18 more drugs

cellular therapy, +4 more types

A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma

~88 mi. (Tel Aviv, Israel, +156 more cities)

Tel Aviv Sourasky Medical Center /ID# 169437

IGH-CCND1 Fusion, +1 more biomarker

Multiple Myeloma

dexamethasone, +1 more drug

chemotherapy, +1 more type

Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis

~88 mi. (Ramat Gan, Israel, +165 more cities)

The Chaim Sheba Medical Center /ID# 219137

del(11)(q10), +27 more biomarkers

Myelofibrosis

navitoclax, +1 more drug

targeted therapy

Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer

~88 mi. (Ramat Gan, Israel, +228 more cities)

The Chaim Sheba Medical Center /ID# 204254

MET Expression

Non-Small Cell Lung Carcinoma

telisotuzumab vedotin

chemotherapy, +1 more type

Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple Myeloma

~88 mi. (Ramat Gan, Israel, +54 more cities)

The Chaim Sheba Medical Center /ID# 229483

Multiple Myeloma

carfilzomib, +4 more drugs

chemotherapy, +3 more types